COMPANY
ACF Equity Research

ACF Equity Research
Accuracy | Clarity | Foresight

61
Insights
26.5k
Views
3
Followers
Equities
Refresh
bullishMerus NV
29 Apr 2025 15:00Issuer-paid

Merus NV - ACF Thematic Oncology Lung Cancer Cough LCC 25042025

Lung Cancer Cough (LCC) is an under-served, perhaps unserved therapeutic subsegment of the Lung Cancer/Oncology market. 57-65% of early diagnosis...

Logo
23 Views
Share
09 Apr 2025 21:00Issuer-paid

BrainStorm Cell Therapeutics (BCLI) - Fundamentals Update 09042025

BrainStorm Cell Therapeutics Inc. (Nasdaq: BCLI) develops NurOwn® stem cell therapy for NDDs – BCLI’s first target is ALS (MND/Lou...

Logo
226 Views
Share
14 Mar 2025 00:29Issuer-paid

ACF Thematic Research Regenerative Medicine Diabetes Treatment & Innovation 13032025

Global economic costs of diabetes may exceed USD1 trn today and USD 450bn in the US, suggesting a pressing global health challenge.

Logo
166 Views
Share
13 Mar 2025 23:13Issuer-paid

AsiaFIN Holdings Corp (ASFH) Pre-Results 4Q24 12032025

AsiaFIN Holdings Corp. (OTCQB : ASFH) – provides IP protected fintech solutions to ASEAN (excluding China & India) based financial institutions /...

Logo
159 Views
Share
14 Feb 2025 02:40Issuer-paid

NLS Pharmaceutics (NLSP) Core Investment Case 13022025

NLS Pharmaceutics (NLSP:NasdaqCM) is a clinical-stage Swiss foreign issuer biotech advancing the Dual Orexin Receptor Agonist (DOXA) platform

Logo
144 Views
Share
x